Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 52, Issue 3, Pages 975-987
Publisher
IOS Press
Online
2016-05-25
DOI
10.3233/jad-151110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Learning by Failing: Ideas and Concepts to Tackle γ-Secretases in Alzheimer's Disease and Beyond
- (2015) Bart De Strooper et al. Annual Review of Pharmacology and Toxicology
- Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?
- (2015) Michelli Erica Souza Ferreira et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity
- (2014) Alfred T. Welzel et al. BIOCHEMISTRY
- Lessons from a Failed γ-Secretase Alzheimer Trial
- (2014) Bart De Strooper CELL
- Proteomic Analysis of C2C12 Myoblast and Myotube Exosome-Like Vesicles: A New Paradigm for Myoblast-Myotube Cross Talk?
- (2014) Alexis Forterre et al. PLoS One
- Neuroprotective effects of resveratrol in Alzheimer disease pathology
- (2014) Shraddha D. Rege et al. Frontiers in Aging Neuroscience
- Successes and Failures for Drugs in Late-Stage Development for Alzheimer’s Disease
- (2013) Camryn Berk et al. DRUGS & AGING
- A cellular model of amyloid precursor protein processing and amyloid-β peptide production
- (2013) MiMi P. Macias et al. JOURNAL OF NEUROSCIENCE METHODS
- Exacerbation of psoriatic skin lesions in a patient with Alzheimer disease receiving gamma-secretase inhibitor
- (2013) Chao-Kai Hsu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- ω-3 Fatty Acids in the Prevention of Cognitive Decline in Humans
- (2013) Tommy Cederholm et al. Advances in Nutrition
- Epidemiology of Dementias and Alzheimer’s Disease
- (2012) Ana Luisa Sosa-Ortiz et al. ARCHIVES OF MEDICAL RESEARCH
- Protein Misfolded Oligomers: Experimental Approaches, Mechanism of Formation, and Structure-Toxicity Relationships
- (2012) Francesco Bemporad et al. CHEMISTRY & BIOLOGY
- Synaptic changes in Alzheimer’s disease and its models
- (2012) J. Pozueta et al. NEUROSCIENCE
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease
- (2011) Wei Zhang et al. BEHAVIOURAL BRAIN RESEARCH
- Aβ Oligomer-Induced Synapse Degeneration in Alzheimer’s Disease
- (2011) Kyle C. Wilcox et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Critical role of cPLA2 in Aβ oligomer-induced neurodegeneration and memory deficit
- (2011) Cédric Desbène et al. NEUROBIOLOGY OF AGING
- Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice
- (2010) Thierry Oster et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
- (2010) Inna Kuperstein et al. EMBO JOURNAL
- Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease
- (2010) Joseph F. Quinn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ciliary Neurotrophic Factor Cell-Based Delivery Prevents Synaptic Impairment and Improves Memory in Mouse Models of Alzheimer's Disease
- (2010) P. Garcia et al. JOURNAL OF NEUROSCIENCE
- Synaptic degeneration in Alzheimer’s disease
- (2009) Thomas Arendt ACTA NEUROPATHOLOGICA
- Cell-derived soluble oligomers of human amyloid-β peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons
- (2009) Ting-Ting Yang et al. JOURNAL OF NEURAL TRANSMISSION
- Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction
- (2009) Jennifer L. Tomic et al. NEUROBIOLOGY OF DISEASE
- Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
- (2008) Dennis J. Selkoe BEHAVIOURAL BRAIN RESEARCH
- N-truncated amyloid-β oligomers induce learning impairment and neuronal apoptosis
- (2007) Ihsen Youssef et al. NEUROBIOLOGY OF AGING
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started